J Pediatr Infect Dis 2014; 09(04): 171-176
DOI: 10.3233/JPI-140434
Georg Thieme Verlag KG Stuttgart – New York

Variation in the clinical presentation of Plasmodium vivax and Plasmodium falciparum malaria in children: A hospital based study in Kanpur, India

Y.K. Rao
a   Department of Pediatrics, GSVM Medical College, Kanpur, India
,
A. Padhye
b   GSVM Medical College, Kanpur, India
,
T. Midha
c   Department of Community Medicine, Govt. Medical College, Kannauj, India
,
D.S. Martolia
c   Department of Community Medicine, Govt. Medical College, Kannauj, India
,
A. Kumar
d   Awadh Hospital, Lucknow, India
,
A. Gupta
e   Department of Pharmacology, GSVM Medical College, Kanpur, India
,
P. Mittal
a   Department of Pediatrics, GSVM Medical College, Kanpur, India
,
B. Papne
f   Department of Pediatrics, Govt. Medical College, Ambedkarnagar, India
› Author Affiliations

Subject Editor:
Further Information

Publication History

14 June 2014

22 September 2014

Publication Date:
28 July 2015 (online)

Abstract

In India, Plasmodium falciparum is recognized as an important cause of pediatric mortality and morbidity. However, recent observations suggest there is an increasing incidence of severe cases of P. vivax, including acute renal failure.

All patients in the age group 0–15 yr, presenting with fever, admitted to the Department of Pediatrics, GSVM Medical College, Kanpur, during the study period were tested for malarial parasites. Those positive for P. vivax and/or P. falciparum were included in the study; clinical findings and laboratory investigations were recorded and analysed.

A total of 112 subjects belonging to the age group 0–15 yr were included in the study. P. vivax was detected in 70 (62.5%) and P. falciparum in 42 (37.5%). Many patients with P. vivax demonstrated signs and symptoms of severe malaria, including respiratory symptoms in 12 (17.1%), abdominal symptoms in 39 (55.7%), central nervous system symptoms in 19 (27.1%), pallor in 60 (85.7%), icterus in 9 (12.9%), edema in 15 (21.4%), hypotension in 3 (4.3%), hepatomegaly in 49 (70%) and splenomegaly in 51 (72.9%). 12.9% of P. vivax patients had acute renal failure (ARF).

There is a rising incidence of P. vivax cases causing severe malaria. ARF, which was previously considered to be only due to P. falciparum, is now also caused by P. vivax. P. vivax should no longer be considered a benign species causing only non-severe malaria.